Einat Galamidi
Förmögenhet: 8 440 $ per 2026-05-31
Förmögenhet: 8 440 $ per 2026-05-31
Einat Galamidi currently works at Enlivex Therapeutics Ltd., as Chief Medical Officer from 2025.
Dr. Galamidi also formerly worked at Gamida Cell Ltd., as Vice President-Clinical Development.
Dr. Galamidi received her doctorate degree from The Hebrew University of Jerusalem.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ENLIVEX LTD. 0 % | 2026-03-18 | 10 420 ( 0 % ) | 8 440 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ENLIVEX | Teknisk/Vetenskaplig/F&U Direktör | 2025-02-01 |
| Företag | Position | Slut |
|---|---|---|
| GAMIDA CELL LTD. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 3 |
|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån